Business
Alkermes Announces Expansion of Patient Services and Provider Network to Support Uninterrupted Access to ARISTADA® and VIVITROL® During COVID-19 Crisis
-- Retail Pharmacies, Including 900 Albertsons Locations, Added to the Provider Locator to Provide Injections of ARISTADA and VIVITROL; Additional Programs In
About this update from Alkermes Plc
[{"type":"text","content":"-- Retail Pharmacies, Including 900 Albertsons Locations, Added to the Provider Locator to Provide Injections of ARISTADA and VIVITROL; Additional Programs In Place to Deliver Support and Financial Assistance --\n\n\nDUBLIN, May 11, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the expansion of several programs and services in support of patient access to its proprietary medicines during the COVID-19 crisis. During this unprecedented and rapidly evolving situation, the company remains focused on helping to assure that patients have uninterrupted access to ARISTADA® (aripiprazole lauroxil), an injectable atypical antipsychotic for the treatment of schizophrenia in adults, and VIVITROL® (naltrexone for extended-release injectable suspension), indicated for the treatment of alcohol dependence and the prevention of relapse to opioid dependence following opioid detoxification. \n\"In these challenging and uncertain times, it is critical that we continue to support people living with opioid dependence, alcohol dependence and schizophrenia,\" said Richard Pops, Chief Executive Officer of Alkermes. \"As COVID-19 and efforts to contain its spread impact access to care for some patients, we are committed to helping assure that patients have access to the medications that may help them. At Alkermes, our work has always been guided by the needs of patients and our dedication has never been stronger or more important than at this moment.\"\nExamples of actions taken to date include:\nExpanding Alkermes' injection site network to include additional appropriate retail pharmacies and clinics where patients can receive injections of ARISTADA and VIVITROL. As part of this initiative, Alkermes has added to its Provider Locator more than 900 on-site retail pharmacies at certain Albertsons Companies locations under the banner names Albertsons, Acme, Jewel-Osco, Pavilions, Randalls, Safeway, Tom Thumb, Shaw's, Star Markets and Vons. Pharmacists at these designated Albertsons Companies locations throughout the U.S. now are available to provide injections of ARISTADA and VIVITROL. These Albertsons sites extend Alkermes' existing Provider Locator network and offer patients additional injection options across the country. The most comprehensive and up-to-date information on active providers and alternative sites of care is available on...